Viewing Study NCT06410833


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-02-17 @ 5:02 PM
Study NCT ID: NCT06410833
Status: RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-04-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Belimumab After Rituximab in Resistant Primary Juvenile SS
Sponsor: Peking Union Medical College Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sjogren's Syndrome View
None Pediatric ALL View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rituximab View
None Belimumab View